Dopamine receptor 2 activation inhibits ovarian vascular endothelial growth factor secretion in an ovarian hyperstimulation syndrome (OHSS) animal model: implications for treatment of OHSS with dopamine receptor 2 agonists-Reference-Cited by-同舟云学术

Dopamine receptor 2 activation inhibits ovarian vascular endothelial growth factor secretion in an ovarian hyperstimulation syndrome (OHSS) animal model: implications for treatment of OHSS with dopamine receptor 2 agonists

Published:2014-11 Issue:5 Volume:102 Page:1468-1476.e1
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Ferrero Hortensia,García-Pascual Carmen M.,Gaytán María,Morales Concepción,Simón Carlos,Gaytán Francisco,Pellicer Antonio,Gómez Raúl

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference34 articles.

1. The pathogenesis of the ovarian hyperstimulation syndrome;Kaiser;N Engl J Med,2003

2. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review;Delvigne;Hum Reprod Update,2002

3. Role of vascular endothelial cell growth factor in ovarian hyperstimulation syndrome;Levin;J Clin Invest,1998

4. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome;McClure;Lancet,1994

5. Human chorionic gonadotropin–dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome;Neulen;J Clin Endocrinol Metab,1995

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogenesis and management in OHSS;Handbook of Current and Novel Protocols for the Treatment of Infertility;2024

2. Cocktail treatment by GnRH-antagonist, letrozole, and mifepristone for the prevention of ovarian hyperstimulation syndrome: a prospective randomized trial;Gynecological Endocrinology;2023-10-16

3. Does cabergoline administration affect endometrial VEGFR-2 expression in a rat model of ovarian hyperstimulation syndrome?;Gynecological Endocrinology;2023-05-29

4. Treatment of Ovarian Hyperstimulation Syndrome in a Mouse Model by Cannabidiol, an Angiogenesis Pathway Inhibitor;BioMed Research International;2022-12-21

5. In Vitro Fertilization for Polycystic Ovarian Syndrome;Clinical Obstetrics & Gynecology;2020-12-28